Annual Total Long Term Liabilities
$171.20 K
+$171.20 K+100.00%
December 1, 2023
Summary
- As of March 10, 2025, SKYE annual total long term liabilities is $171.20 thousand, with the most recent change of +$171.20 thousand (+100.00%) on December 1, 2023.
- During the last 3 years, SKYE annual total long term liabilities has fallen by -$1.26 million (-88.06%).
- SKYE annual total long term liabilities is now -93.04% below its all-time high of $2.46 million, reached on December 1, 2015.
Performance
SKYE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$108.10 K
-$21.80 K-16.78%
September 1, 2024
Summary
- As of March 10, 2025, SKYE quarterly total long term liabilities is $108.10 thousand, with the most recent change of -$21.80 thousand (-16.78%) on September 1, 2024.
- Over the past year, SKYE quarterly long term liabilities has stayed the same.
- SKYE quarterly long term liabilities is now -98.74% below its all-time high of $8.59 million, reached on March 1, 2018.
Performance
SKYE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SKYE Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | 0.0% |
| 3 y3 years | -88.1% | 0.0% |
| 5 y5 years | -89.2% | 0.0% |
SKYE Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -48.2% | -100.0% |
| 5 y | 5-year | -88.1% | -100.0% | -94.4% | -100.0% |
| alltime | all time | -93.0% | -100.0% | -98.7% | -100.0% |
Skye Bioscience Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $108.10 K(-16.8%) |
| Jun 2024 | - | $129.90 K(-14.0%) |
| Mar 2024 | - | $151.00 K(-11.8%) |
| Dec 2023 | $171.20 K(>+9900.0%) | $171.20 K(-10.1%) |
| Sep 2023 | - | $190.50 K(-8.7%) |
| Jun 2023 | - | $208.60 K(>+9900.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2022 | - | $8200.00(-74.7%) |
| Jun 2022 | - | $32.40 K(-42.0%) |
| Mar 2022 | - | $55.90 K(-29.0%) |
| Dec 2021 | $78.70 K(-94.5%) | $78.70 K(-95.9%) |
| Sep 2021 | - | $1.92 M(+15.1%) |
| Jun 2021 | - | $1.67 M(+8.7%) |
| Mar 2021 | - | $1.54 M(+7.1%) |
| Dec 2020 | $1.43 M(+200.0%) | $1.43 M(+11.5%) |
| Sep 2020 | - | $1.29 M(+10.2%) |
| Jun 2020 | - | $1.17 M(+64.6%) |
| Mar 2020 | - | $708.70 K(+48.3%) |
| Dec 2019 | $477.90 K(-69.8%) | $477.90 K(-87.6%) |
| Sep 2019 | - | $3.86 M(+6.8%) |
| Jun 2019 | - | $3.62 M(-6.7%) |
| Mar 2019 | - | $3.88 M(+145.4%) |
| Dec 2018 | $1.58 M | $1.58 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(-100.0%) |
| Mar 2018 | - | $8.59 M(+1458.0%) |
| Dec 2017 | $551.30 K(-50.4%) | $551.30 K(-30.4%) |
| Sep 2017 | - | $791.80 K(-26.2%) |
| Jun 2017 | - | $1.07 M(-2.4%) |
| Mar 2017 | - | $1.10 M(-1.1%) |
| Dec 2016 | $1.11 M(-54.8%) | $1.11 M(+27.9%) |
| Sep 2016 | - | $870.00 K(+2.9%) |
| Jun 2016 | - | $845.60 K(-70.5%) |
| Mar 2016 | - | $2.87 M(+16.7%) |
| Dec 2015 | $2.46 M(>+9900.0%) | $2.46 M(-15.1%) |
| Sep 2015 | - | $2.90 M(>+9900.0%) |
| Jun 2015 | - | $2400.00(+50.0%) |
| Mar 2015 | - | $1600.00(+100.0%) |
| Dec 2014 | $800.00(>+9900.0%) | $800.00(>+9900.0%) |
| Sep 2014 | - | $0.00(-100.0%) |
| Jul 2014 | - | $43.00 K(>+9900.0%) |
| Apr 2014 | - | $0.00(0.0%) |
| Jan 2014 | - | $0.00(0.0%) |
| Oct 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Jul 2013 | - | $0.00(-100.0%) |
| Apr 2013 | - | $15.90 K(>+9900.0%) |
| Oct 2012 | $0.00 | $0.00 |
FAQ
- What is Skye Bioscience annual total long term liabilities?
- What is the all time high annual total long term liabilities for Skye Bioscience?
- What is Skye Bioscience annual total long term liabilities year-on-year change?
- What is Skye Bioscience quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Skye Bioscience?
- What is Skye Bioscience quarterly long term liabilities year-on-year change?
What is Skye Bioscience annual total long term liabilities?
The current annual total long term liabilities of SKYE is $171.20 K
What is the all time high annual total long term liabilities for Skye Bioscience?
Skye Bioscience all-time high annual total long term liabilities is $2.46 M
What is Skye Bioscience annual total long term liabilities year-on-year change?
Over the past year, SKYE annual total long term liabilities has changed by +$171.20 K (+100.00%)
What is Skye Bioscience quarterly total long term liabilities?
The current quarterly long term liabilities of SKYE is $108.10 K
What is the all time high quarterly long term liabilities for Skye Bioscience?
Skye Bioscience all-time high quarterly total long term liabilities is $8.59 M
What is Skye Bioscience quarterly long term liabilities year-on-year change?
Over the past year, SKYE quarterly total long term liabilities has changed by $0.00 (0.00%)